Classer les publications sur l'année
-
Pharmaco-Epidémiologie
Blindness, low vision, and other handicaps as risk factors attached to institutional residence
BREZIN A,LAFUMA A, FAGNANI F, MESBAH M, BERDEAUX G
Br J Ophtalmol ; 88(10):1330-1337
-
Pharmaco-Epidémiologie
An epidemiological model of genital herpes : application to France
BOELLE PY, DETOURNAY B, VALLERON PJ, FAGNANI F, HALIOUA B, NICOLAS JC
Ann Dermatol Venereol ; 131(1 Pt 1):17-26
-
Pharmaco-Epidémiologie
A population-based study of diabetes and its characteristics during the fasting month of ramadan in 13 countries
SALTI I, BĂNARD E, DETOURNAY B, BIANCHI-BISCAY M, LE BRIGAND C, VOINET C, JABBAR A
Diabetes Care ; 27(10):2306-2311
-
Pharmaco-Epidémiologie
A multicenter pharmacoepidemiological study of therapeutic practices in invasive fungal infections in France during 1998-1999
LORTHOLARY O, CHARLEMAGNE A, BASTIDES F, CHEVALIER P, DATRY A, GONZALVES MF, MICHEL G, TILLEUL P, VEBER B, HERBRECHT R
J Antimicrob Chemother ; 54(2):456-64
-
Ăconomie de la santĂ©
Effectiveness and cost of contraception in France (FACET study): a cohort study from the French National Healthcare Insurance Database.
AGOSTINI A, GODARD C, LAURENDEAU C, BENMAHMOUD A, LAFUMA A, DOZ M, LEVY-BACHELOT L, GOURMELEN J, LINET T.
European Journal of Obstetrics & Gynecology and Reproductive Biology ; 2018;229: 137â143
-
Autres
Care pathway, towards the establishment of tailored funding: Reasons and criteria for success.
EMERY G, LE FUR C, EPIS-DE-FLEURIAN AA, JOSSERAN A; Participants of Giens Round Table ‘Medico-economy’ of Giens XXXIII.
Therapie ; 2018;73(1):33-40
-
Pharmaco-Epidémiologie
Health related quality of life in patients with community-acquired pneumococcal pneumonia in France.
ANDRADE LF, SABA G, RICARD JD, MESSIKA J, GAILLAT J, BONNIN P, CHIDIAC C, ILLES HG, LAURICHESSE H, DETOURNAY B, PETITPRETZ P, DE POUVOURVILLE G.
Health Qual Life Outcomes ; 2018;16 (1):28
-
Ăconomie de la santĂ©
Direct Medical Costs of Type 2 Diabetes in France: An Insurance Claims Database Analysis.
CHARBONNEL B, SIMON D, DALLONGEVILLE J, BUREAU I, DEJAGER S, LEVY-BACHELOT L, GOURMELEN J, DETOURNAY B.
Pharmacoecon Open ; 2018;2(2):209-219
-
Ăconomie de la santĂ©
Le traitement du diabĂšte de type 2 en France est dynamique plutĂŽt quâinerte : analyse des prescriptions de 847 122 patients.
ROUSSEL R, FONTAINE P, GOUET D, SERUSCLAT P, MARTINEZ L, DETOURNAY B, MARTIN-KRISTENSEN M.
Med Mal Metab ; 2018;12(4):346-352
-
Pharmaco-Epidémiologie
L’Ă©valuation risque/bĂ©nĂ©fice dans les domaines de la santĂ© et de l’environnement : similitudes et diffĂ©rences
FAGNANI F
Environnement Risques & Santé ; 1(3):1-3
-
Pharmaco-Epidémiologie
Prise de position de la SociĂ©tĂ© Francophone du DiabĂšte (SFD) sur la prise en charge mĂ©dicamenteuse de lâhyperglycĂ©mie du patient diabĂ©tique de type 2.
DARMON P, BAUDUCEAU B, BORDIER L, BRINGER J, CHABRIER G, CHARBONNEL B, DETOURNAY B, FONTAINE P, GRIMALDI A, GOURDY P, GUERCI B, PENFORNIS A, RIVELINE JP, SCHEEN A.
Med Mal Metab ; 2017;11(6):577-593
-
Pharmaco-Epidémiologie
DIABEO App Software and Telemedicine Versus Usual Follow-Up in the Treatment of Diabetic Patients: Protocol for the TELESAGE Randomized Controlled Trial
JEANDIDIER N, CHAILLOUS L, FRANC S, BENHAMOU PY, SCHAEPELYNCK P, HANAIRE H, CATARGI B, FARRET A, FONTAINE P, GUERCI B, REZNIK Y, PENFORNIS A, BOROT S, SERUSCLAT P, KHERBACHI Y, D’ORSAY G, DETOURNAY B, SIMON P, CHARPENTIER G
JMIR Res Protoc ; 2018;7 (4)
-
Pharmaco-Epidémiologie
Indices de satisfaction des patients atteints d’une dystrophie musculaire de Duchenne de Boulogne et ventilĂ©s Ă domicile
RAPHAEL JC, DAZORD A, JAILLARD P, ANDRONIKOF-SANGLADE A, BENONY H, KOVESS V, CHARPAK Y, AURIANT I
La Revue Neurologique ; 4 (158) : 453-460
-
Ăconomie de la santĂ©
Clinical outcomes of glaucoma Treatments Over a patient lifetime : a Markov Model
NORDMANN JP, LAFUMA A, DESCHASEAUX-VOINET C, BERDEAUX G
J Glaucoma ; 14(6):463-469
-
Santé publique
Breast cancer screening in France
PHILIP T, KASPARIAN C, FAGNANI F, MOATTI JP, MEUNIER A
Bull Acad Natl Med ; 189(2):321-336
  Â